Overview

Mice Model Market is poised to value over USD 2.1 billion by 2027 end at a CAGR of over 6.4% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Mice Model Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Mice Model Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Mice Model Market:
• CHARLES RIVER LABORATORIES INTERNATIONAL
• THE JACKSON LABORATORY
• ENVIGO
• GENOWAY
• TACONIC BIOSCIENCES, INC.
• JANVIER LABS
• HARBOUR BIOMED
• TRANS GENIC, INC.
• INGENIOUS TARGETING LABORATORY
• POLYGENE
• GVK BIO
• CYAGEN BIOSCIENCES
• CROWN BIOSCIENCE INC. (A SUBSIDIARY OF JSR CORPORATION)
• TRANSCURE BIOSERVICES
• OZGENE PTY LTD
• THE ANDERSONS, INC.
• FENGSHI GROUP
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Mice Model Market Segmentation:
By Mice Type
• Inbred Mice
• Genetically Engineered Mice
• Outbred Mice
• Hybrid/Congenic Mice
• Conditioned/Surgically Modified Mice
• Spontaneous Mutant Mice

By Service
• Breeding
• Cryopreservation
• Quarantine
• Rederivation
• Model-in licensing
• Genetic Testing
• Other Services

By Application
• Oncology Studies
• Immunology and Inflammation Studies
• Endocrine Metabolic Studies
  o Diabetes
• Cardiovascular Studies
• Central Nervous System (CNS) Studies
• Genetic Studies
• Infectious Disease Studies
• Other Disease Studies

By Technology
• CRISPR/CAS9
• Microinjection
• Embryonic Stem cell Injection
• Nuclear Transfer
• Other Technologies

By Mice Care Product
• Cages
• Feed
• Bedding
• Other Care Products

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Mice Model Market By Mice Type, By Service, By Application, By Technology, By Mice Care Product and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Mice Model Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Mice Model Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Mice Model Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Global Mice Model Market, By Mice Type Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Inbred Mice
  7.2. Genetically Engineered Mice
  7.3. Outbred Mice
  7.4. Hybrid/Congenic Mice
  7.5. Conditioned/Surgically Modified Mice
  7.6. Spontaneous Mutant Mice

8. Global Mice Model Market, By Service Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. Breeding
  8.2. Cryopreservation
  8.3. Quarantine
  8.4. Rederivation
  8.5. Model-in licensing
  8.6. Genetic Testing
  8.7. Other Services

9. Global Mice Model Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Oncology Studies
  9.2. Immunology and Inflammation Studies
  9.3. Endocrine Metabolic Studies
       9.3.1. Diabetes
  9.4. Cardiovascular Studies
  9.5. Central Nervous System (CNS) Studies
  9.6. Genetic Studies
  9.7. Infectious Disease Studies
  9.8. Other Disease Studies

10. Global Mice Model Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million)
  10.1. CRISPR/CAS9
  10.2. Microinjection
  10.3. Embryonic Stem cell Injection
  10.4. Nuclear Transfer
  10.5. Other Technologies

11. Global Mice Model Market, By Mice Care Product Historical Analysis and Forecast 2020-2027 (USD Million)
  11.1. Cages
  11.2. Feed
  11.3. Bedding
  11.4. Other Care Products

12. North America Mice Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  12.1. Introduction
  12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       12.2.1. U.S.A
       12.2.2. Canada
       12.2.3. Mexico
  12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Mice Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         13.2.1. Brazil
         13.2.2. Venezuela
         13.2.3. Argentina
         13.2.4. Rest of Latin America
   13.3. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Mice Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         14.2.1. Germany
         14.2.2. U.K        
         14.2.3. France
         14.2.4. Italy
         14.2.5. Spain
         14.2.6. Russia
         14.2.7. Poland
         14.2.8. Rest of Europe
   14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Mice Model Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   15.1. Introduction
   15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         15.2.1. Japan
         15.2.2. China
         15.2.3. India
         15.2.4. Australia and New Zealand
         15.2.5. ASEAN
         15.2.6. Rest of Asia Pacific
   15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
   16.1. Introduction
   16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         16.2.1. Saudi Arabia
         16.2.2. UAE
         16.2.3. South Africa
         16.2.4. Egypt
   16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Market Share Analysis and Competitive Landscape  
   17.1. Global Landscape - Key Players, Revenue and Presence
   17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   17.3. Global Emerging Companies
   17.4.  North America - Market Share Analysis and Key Regional Players
   17.5.  Europe - Market Share Analysis and Key Regional Players
   17.6.  Asia Pacific - Market Share Analysis and Key Regional Players
   17.7.  Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   18.1. CHARLES RIVER LABORATORIES INTERNATIONAL
         18.1.1. Company Overview
         18.1.2. Product Portfolio
         18.1.3. SWOT Analysis
         18.1.4. Financial Overview
         18.1.5. Strategic Overview
   18.2. THE JACKSON LABORATORY
         18.2.1. Company Overview
         18.2.2. Product Portfolio
         18.2.3. SWOT Analysis
         18.2.4. Financial Overview
         18.2.5. Strategic Overview
   18.3. ENVIGO
         18.3.1. Company Overview
         18.3.2. Product Portfolio
         18.3.3. SWOT Analysis
         18.3.4. Financial Overview
         18.3.5. Strategic Overview
   18.4. GENOWAY
         18.4.1. Company Overview
         18.4.2. Product Portfolio
         18.4.3. SWOT Analysis
         18.4.4. Financial Overview
         18.4.5. Strategic Overview
   18.5 TACONIC BIOSCIENCES, INC.
         18.5.1. Company Overview
         18.5.2. Product Portfolio
         18.5.3. SWOT Analysis
         18.5.4. Financial Overview
         18.5.5. Strategic Overview          
   18.6 JANVIER LABS
         18.6.1. Company Overview
         18.6.2. Product Portfolio
         18.6.3. SWOT Analysis
         18.6.4. Financial Overview
         18.6.5. Strategic Overview      
   18.7. HARBOUR BIOMED
         18.7.1. Company Overview
         18.7.2. Product Portfolio
         18.7.3. SWOT Analysis
         18.7.4. Financial Overview
         18.7.5. Strategic Overview
   18.8. TRANS GENIC, INC.
         18.8.1. Company Overview
         18.8.2. Product Portfolio
         18.8.3. SWOT Analysis
         18.8.4. Financial Overview
         18.8.5. Strategic Overview
   18.9. INGENIOUS TARGETING LABORATORY
         18.9.1. Company Overview
         18.9.2. Product Portfolio
         18.9.3. SWOT Analysis
         18.9.4. Financial Overview
         18.9.5. Strategic Overview
   18.10. POLYGENE
         18.10.1. Company Overview
         18.10.2. Product Portfolio
         18.10.3. SWOT Analysis
         18.10.4. Financial Overview
         18.10.5. Strategic Overview
   18.11.GVK BIO
         18.11.1. Company Overview
         18.11.2. Product Portfolio
         18.11.3. SWOT Analysis
         18.11.4. Financial Overview
         18.11.5. Strategic Overview
   18.12.CYAGEN BIOSCIENCES
         18.12.1. Company Overview
         18.12.2. Product Portfolio
         18.12.3. SWOT Analysis
         18.12.4. Financial Overview
         18.12.5. Strategic Overview
   18.13.CROWN BIOSCIENCE INC. (A SUBSIDIARY OF JSR CORPORATION)
         18.13.1. Company Overview
         18.13.2. Product Portfolio
         18.13.3. SWOT Analysis
         18.13.4. Financial Overview
         18.13.5. Strategic Overview
   18.14.TRANSCURE BIOSERVICES
         18.14.1. Company Overview
         18.14.2. Product Portfolio
         18.14.3. SWOT Analysis
         18.14.4. Financial Overview
         18.14.5. Strategic Overview
   18.15.OZGENE PTY LTD
         18.15.1. Company Overview
         18.15.2. Product Portfolio
         18.15.3. SWOT Analysis
         18.15.4. Financial Overview
         18.15.5. Strategic Overview          
   18.16.THE ANDERSONS, INC.
         18.16.1. Company Overview
         18.16.2. Product Portfolio
         18.16.3. SWOT Analysis
         18.16.4. Financial Overview
         18.16.5. Strategic Overview      
   18.17.FENGSHI GROUP
         18.17.1. Company Overview
         18.17.2. Product Portfolio
         18.17.3. SWOT Analysis
         18.17.4. Financial Overview
         18.17.5. Strategic Overview
     
19. Pre and Post COVID-19 Impact
   19.1. Positive influence on the healthcare industry
   19.2. The financial disruption of the manufacturing sector
   19.3. Impact of COVID-19 on emerging companies
   19.4. Significant mandates in the healthcare regulations initiated by administrations
   19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures